1. Home
  2. ARVN vs ATGL Comparison

ARVN vs ATGL Comparison

Compare ARVN & ATGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARVN
  • ATGL
  • Stock Information
  • Founded
  • ARVN 2015
  • ATGL 2017
  • Country
  • ARVN United States
  • ATGL Hong Kong
  • Employees
  • ARVN N/A
  • ATGL N/A
  • Industry
  • ARVN Biotechnology: Pharmaceutical Preparations
  • ATGL
  • Sector
  • ARVN Health Care
  • ATGL
  • Exchange
  • ARVN Nasdaq
  • ATGL Nasdaq
  • Market Cap
  • ARVN 456.2M
  • ATGL 407.0M
  • IPO Year
  • ARVN 2018
  • ATGL 2023
  • Fundamental
  • Price
  • ARVN $6.79
  • ATGL $18.37
  • Analyst Decision
  • ARVN Buy
  • ATGL
  • Analyst Count
  • ARVN 22
  • ATGL 0
  • Target Price
  • ARVN $20.21
  • ATGL N/A
  • AVG Volume (30 Days)
  • ARVN 2.1M
  • ATGL 2.3K
  • Earning Date
  • ARVN 08-06-2025
  • ATGL 01-01-0001
  • Dividend Yield
  • ARVN N/A
  • ATGL N/A
  • EPS Growth
  • ARVN N/A
  • ATGL N/A
  • EPS
  • ARVN N/A
  • ATGL N/A
  • Revenue
  • ARVN $372,800,000.00
  • ATGL $1,590,148.00
  • Revenue This Year
  • ARVN $7.57
  • ATGL N/A
  • Revenue Next Year
  • ARVN N/A
  • ATGL N/A
  • P/E Ratio
  • ARVN N/A
  • ATGL N/A
  • Revenue Growth
  • ARVN 299.57
  • ATGL 42.17
  • 52 Week Low
  • ARVN $5.90
  • ATGL $1.15
  • 52 Week High
  • ARVN $29.61
  • ATGL $57.32
  • Technical
  • Relative Strength Index (RSI)
  • ARVN 41.59
  • ATGL 29.87
  • Support Level
  • ARVN $6.06
  • ATGL $15.00
  • Resistance Level
  • ARVN $7.83
  • ATGL $21.90
  • Average True Range (ATR)
  • ARVN 0.40
  • ATGL 0.37
  • MACD
  • ARVN -0.11
  • ATGL -0.20
  • Stochastic Oscillator
  • ARVN 34.93
  • ATGL 48.77

About ARVN Arvinas Inc.

Arvinas Inc is a United States-based biopharmaceutical company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and commercialization of therapies that degrade disease-causing proteins.. The company's proprietary Proteolysis-Targeting Chimera (PROTAC), work by inducing the cell's own ubiquitin-proteasome system to target, degrade and remove disease-causing proteins. The group's product candidates are bavdegalutamide, ARV-471 and ARV-766.

About ATGL Alpha Technology Group Limited

Alpha Technology Group Ltd operates through its subsidiaries, which are established cloud-based IT solution service providers in Hong Kong. Its Operating Subsidiaries utilize its analytic skills, programming skills, artificial intelligence technologies and technological know-how to provide comprehensive solutions designed to optimize the business performance of customers, meet various industry-specific operational challenges of customers and create new business opportunities for customers. The Operating Subsidiaries provide services for customers from a variety of industries, including consulting, real estate, architectural design, carpark management, electronic payment services, logistics, investments, retail, textiles, wholesale and distribution, etc.

Share on Social Networks: